Cellular mechanisms for diastolic dysfunction in the human heart
Dániel Czuriga1, Walter J Paulus, István Czuriga
1Division of Clinical Physiology, Institute of Cardiology, University of Debrecen, Medical and Health Science Center, Hungary.
Insights
Left ventricular diastolic dysfunction, a key factor in cardiovascular diseases, involves impaired relaxation and filling. This review explores the diverse cellular mechanisms underlying diastolic dysfunction across various heart conditions.
Area of Science:
- Cardiology
- Molecular Biology
- Pathophysiology
Background:
- Left ventricular (LV) diastolic dysfunction is a significant factor in numerous cardiovascular diseases.
- It manifests as impaired LV relaxation, filling, or increased stiffness.
- Diastolic abnormalities are observed in aging hearts, heart failure with preserved ejection fraction (HFPEF), diabetic cardiomyopathy, aortic valve stenosis (AVS), hypertrophic cardiomyopathy (HCM), and Fabry disease (FD).
Purpose of the Study:
- To review and summarize the cellular and molecular mechanisms contributing to diastolic dysfunction in various cardiovascular pathologies.
- To elucidate the divergent underlying mechanisms of diastolic deterioration across different cardiac diseases.
Main Methods:
- Review of existing clinical and experimental studies.
- Analysis of research on cardiomyocyte function, myofilament changes, extracellular matrix alterations, and advanced glycation end products (AGEs).
Main Results:
- Cellular and molecular alterations in diastolic dysfunction are not fully characterized across all mentioned cardiac conditions.
- Studies have investigated cardiomyocyte function, myofilament changes, collagen deposition, and AGE cross-linking.
- Evidence suggests that the mechanisms of LV diastolic dysfunction vary significantly depending on the specific cardiac pathology.
Conclusions:
- The underlying mechanisms of left ventricular diastolic dysfunction are diverse and context-dependent.
- A comprehensive understanding of cellular and molecular alterations is crucial for addressing diastolic dysfunction in various cardiovascular diseases.
- Further research is needed to fully characterize these mechanisms for targeted therapeutic strategies.
Abstract:
Left ventricular (LV) diastolic dysfunction is an important contributor to many different cardiovascular diseases. LV diastolic dysfunction can manifest itself as slow LV relaxation, slow LV filling or high diastolic LV stiffness. Diastolic abnormalities have been described in the senescent heart, in heart failure with preserved ejection fraction (HFPEF), in diabetic cardiomyopathy, in aortic valve stenosis (AVS), in hypertrophic cardiomyopathy (HCM), as well as in Fabry disease (FD), however, exact cellular and molecular alterations behind the diastolic deterioration in these diseases are not yet completely characterized. Several studies thoroughly investigated altered cardiomyocyte function, changes of contractile myofilaments, extracellular collagen deposition and advanced glycation end products (AGEs) cross-linking in the background of diastolic dysfunction. These clinical and experimental data suggest that underlying mechanisms of LV diastolic dysfunction are divergent in different cardiac pathologies, therefore the present review aims to summarize mechanisms at the cellular level of diastolic abnormalities in various cardiovascular diseases.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy


